JP2024546096A5 - - Google Patents
Info
- Publication number
- JP2024546096A5 JP2024546096A5 JP2024533985A JP2024533985A JP2024546096A5 JP 2024546096 A5 JP2024546096 A5 JP 2024546096A5 JP 2024533985 A JP2024533985 A JP 2024533985A JP 2024533985 A JP2024533985 A JP 2024533985A JP 2024546096 A5 JP2024546096 A5 JP 2024546096A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- deletion
- substitution
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163286719P | 2021-12-07 | 2021-12-07 | |
| US63/286,719 | 2021-12-07 | ||
| PCT/US2022/052099 WO2023107538A2 (en) | 2021-12-07 | 2022-12-07 | Binders of chondroitin sulfate proteoglycan (cspg4) polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546096A JP2024546096A (ja) | 2024-12-17 |
| JP2024546096A5 true JP2024546096A5 (cg-RX-API-DMAC7.html) | 2025-12-09 |
Family
ID=86731156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533985A Pending JP2024546096A (ja) | 2021-12-07 | 2022-12-07 | コンドロイチン硫酸プロテオグリカン(cspg4)ポリペプチドの結合剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250313648A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444753A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024546096A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023107538A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012503203A (ja) * | 2008-09-19 | 2012-02-02 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 基底乳癌腫の診断および処置のためのcspg4に対するモノクローナル抗体 |
| US10093745B2 (en) * | 2013-05-29 | 2018-10-09 | The Regents Of The University Of California | Anti-CSPG4 fusions with interferon for the treatment of malignancy |
| EP3218413A4 (en) * | 2014-11-12 | 2018-03-28 | Memorial Sloan-Kettering Cancer Center | Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof |
| WO2016164429A1 (en) * | 2015-04-06 | 2016-10-13 | The General Hospital Corporation | Anti-cspg4 chimeric antigen receptors |
| AU2019287676A1 (en) * | 2018-06-13 | 2021-01-07 | The General Hospital Corporation | Methods and compositions for chimeric antigen receptor targeting cancer cells |
-
2022
- 2022-12-07 WO PCT/US2022/052099 patent/WO2023107538A2/en not_active Ceased
- 2022-12-07 JP JP2024533985A patent/JP2024546096A/ja active Pending
- 2022-12-07 US US18/717,696 patent/US20250313648A1/en active Pending
- 2022-12-07 EP EP22905067.9A patent/EP4444753A4/en active Pending